| Market Cap | $49.2M | |
| Enterprise Value | — | |
| Revenue | $2.9M | — |
| Gross Profit | $271,018 | — |
| EBITDA | -$5.0M | — |
| Net Income | -$4.5M | — |
| Diluted EPS | -$0.16 | — |
| Free Cash Flow | -$7.0M | — |
| Ratio | 2024 | 2025 | Trend · 2y | vs own | vs sector |
|---|---|---|---|---|---|
| ▾Margins | |||||
| Gross Margin | — | 0.68% | — | 50% | 3% |
| Operating Margin | — | −93.92% | — | 50% | 6% |
| EBITDA Margin | — | −84.38% | — | 50% | 6% |
| NOPAT Margin | — | −74.20% | — | 50% | 4% |
| Net Margin | — | −82.00% | — | 50% | 6% |
| FCF Margin | — | −109.01% | — | 50% | 4% |
| OCF Margin | — | −105.77% | — | 50% | 4% |
| Gross Profitability | — | 0.13% | — | 50% | 3% |
| Capex Intensity | — | 3.24% | — | 50% | 61% |
| ▸Returns on Capital · 3 ratios | |||||
| ▸DuPont factors (ROE drivers) · 2 ratios | |||||
| ▸Liquidity & coverage · 2 ratios | |||||
| ▸Leverage · 2 ratios | |||||
| ▸Working capital · 5 ratios | |||||
| ▸Per share · 6 ratios | |||||
| Line | 2025↗ |
|---|---|
| Revenue | $2.7M |
| Cost of Revenue | $2.6M |
| Gross Profit | $18,211 |
| R&D Expense | $922,772 |
| SG&A Expense | $1.6M |
| Total Operating Expenses | $2.5M |
| Operating Income | -$2.5M |
| Other Non-Operating Income | $21,285 |
| Impairment of Real Estate | $0 |
| Pretax Income | -$2.3M |
| Income Tax | -$105,098 |
| Net Income (incl. NCI) | -$2.2M |
| Net Income | -$2.2M |
| EPS (Basic) | -$0.16 |
| EPS (Diluted) | -$0.16 |
| Weighted Avg Shares (Basic) | 14.0M |
| Weighted Avg Shares (Diluted) | 14.0M |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
